| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.21 | 0.2 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.24 | 0.2 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |